Expression of multidrug resistance-related markers in primary neuroblastoma / 中华医学杂志(英文版)
Chinese Medical Journal
;
(24): 1358-1363, 2004.
Artículo
en Inglés
| WPRIM
| ID: wpr-291920
ABSTRACT
<p><b>BACKGROUND</b>Multidrug resistance is associated with a poor prognosis in various human cancers. However, the clinical significance of the expression of multidrug resistance-related markers in neuroblastoma is still on debate. In this study, the effect of the expression of p-glycoprotein (P-gp), multidrug resistance-associated protein (MRP), and lung resistance protein (LRP) in neuroblastoma was evaluated.</p><p><b>METHODS</b>The streptavidin-biotin immunoperoxidase (SP) technique was used to evaluate the expression of P-gp, MRP, and LRP in 70 cases of untreated primary neuroblastoma.</p><p><b>RESULTS</b>The frequencies of the expression of P-gp, MRP, and LRP were 61.4%, 38.6%, and 24.3%, respectively. A significant positive correlation was observed between P-gp and MRP expression (P=0.001), as well as between LRP and MRP expression (P=0.01). The rates of expression of P-gp and MRP were higher in tumors from patients aged greater than one year old than in tumors from patients aged less than 1 year old at time of diagnosis (P=0.01 and 0.018, respectively). MRP expression in tumors that had metastasized was significantly more frequent than in tumors that had not metastasized (P=0.015). The expression of all tested proteins showed a significant relationship with whether or not the tumor had differentiated (P=0.006, 0.000 or 0.001, respectively). MRP expression was significantly associated with a reduction in both median survival time and 2-year cumulative survival (P=0.02). By contrast, P-gp and MRP expression did not correlate with survival. According to Cox regression analysis, only the co-expression of P-gp and MRP had significant prognostic value (relative hazard, 3.513, P=0.033).</p><p><b>CONCLUSIONS</b>The intrinsic, multidrug resistance of neuroblastoma involves the combined effects of P-gp, MRP, and LRP. MRP expression may be an important factor determining prognosis in neuroblastoma.</p>
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Patología
/
Pronóstico
/
Inmunohistoquímica
/
Química
/
Miembro 1 de la Subfamilia B de Casetes de Unión a ATP
/
Resistencia a Antineoplásicos
/
Partículas Ribonucleoproteicas en Bóveda
/
Proteínas Asociadas a Resistencia a Múltiples Medicamentos
/
Quimioterapia
/
Proteínas de Neoplasias
Tipo de estudio:
Estudio pronóstico
Límite:
Adolescente
/
Niño
/
Child, preschool
/
Femenino
/
Humanos
/
Lactante
/
Masculino
Idioma:
Inglés
Revista:
Chinese Medical Journal
Año:
2004
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS